162 related articles for article (PubMed ID: 25824587)
1. Management of immune thrombocytopenia in adults: a population-based analysis of the French hospital discharge database from 2009 to 2012.
Michel M; Suzan F; Adoue D; Bordessoule D; Marolleau JP; Viallard JF; Godeau B
Br J Haematol; 2015 Jul; 170(2):218-22. PubMed ID: 25824587
[TBL] [Abstract][Full Text] [Related]
2. Gender-related analysis of the clinical presentation, treatment response and outcome in patients with immune thrombocytopenia.
Andrès E; Mecili M; Fothergill H; Zimmer J; Vogel T; Maloisel F
Presse Med; 2012 Sep; 41(9 Pt 1):e426-31. PubMed ID: 22459990
[TBL] [Abstract][Full Text] [Related]
3. Patterns of inpatient care for newly diagnosed immune thrombocytopenia in US children's hospitals.
Kime C; Klima J; Rose MJ; O'Brien SH
Pediatrics; 2013 May; 131(5):880-5. PubMed ID: 23569091
[TBL] [Abstract][Full Text] [Related]
4. Need for an improved vaccination rate in primary immune thrombocytopenia patients exposed to rituximab or splenectomy. A nationwide population-based study in France.
Moulis G; Lapeyre-Mestre M; Mahévas M; Montastruc JL; Sailler L
Am J Hematol; 2015 Apr; 90(4):301-5. PubMed ID: 25557586
[TBL] [Abstract][Full Text] [Related]
5. Appropriate hospital management of adult immune thrombocytopenic purpura patients in major Italian institutions in 2000-2002: a retrospective analysis.
Cirasino L; Robino AM; Cattaneo M; Pioltelli PE; Pogliani EM; Terranova L; Morra E; Colombo P; Palmieri GA; Piscitelli P
Blood Coagul Fibrinolysis; 2010 Jan; 21(1):77-84. PubMed ID: 19858712
[TBL] [Abstract][Full Text] [Related]
6. [Idiopathic thrombocytopenic purpura (ITP) in children].
Rajantie J
Duodecim; 2011; 127(19):2081-6. PubMed ID: 22073540
[TBL] [Abstract][Full Text] [Related]
7. Length of stay, hospitalization cost, and in-hospital mortality in US adult inpatients with immune thrombocytopenic purpura, 2006-2012.
An R; Wang PP
Vasc Health Risk Manag; 2017; 13():15-21. PubMed ID: 28176930
[TBL] [Abstract][Full Text] [Related]
8. Risk factors of hospitalisation for thrombosis in adults with primary immune thrombocytopenia, including disease-specific treatments: a French nationwide cohort study.
Lafaurie M; Maquet J; Baricault B; Ekstrand C; Christiansen CF; Linder M; Bahmanyar S; Nørgaard M; Sailler L; Lapeyre-Mestre M; Sommet A; Moulis G
Br J Haematol; 2021 Nov; 195(3):456-465. PubMed ID: 34386974
[TBL] [Abstract][Full Text] [Related]
9. [Management of immune thrombocytopenia in France before the era of thrombopoietin receptor agonists].
Michel M; Doz M; Leclerc-Teffahi S; Detournay B; Lévy-Bachelot L
Rev Med Interne; 2012 Jun; 33(6):305-10. PubMed ID: 22444115
[TBL] [Abstract][Full Text] [Related]
10. Current therapies in primary immune thrombocytopenia.
Pels SG
Semin Thromb Hemost; 2011 Sep; 37(6):621-30. PubMed ID: 22102265
[TBL] [Abstract][Full Text] [Related]
11. Cost and mortality associated with hospitalizations in patients with immune thrombocytopenic purpura.
Danese MD; Lindquist K; Gleeson M; Deuson R; Mikhael J
Am J Hematol; 2009 Oct; 84(10):631-5. PubMed ID: 19705429
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of idiopathic thrombocytopenic purpura in adults: efficacy of domestic intravenous immunoglobulin in immune thrombocytopenia].
Pugina SA; Evdokimova NM; Rastorguev GG; Samoĭlova OS; Sorokina IV; Sidnev GV; Vasil'ev DM; Anastasiev VV; Milovidova OV; Molodovskaia EV; Borovkov NN
Ter Arkh; 1999; 71(8):50-4. PubMed ID: 10515038
[TBL] [Abstract][Full Text] [Related]
13. Immune thrombocytopenia in the elderly: clinical course in 525 patients from a single center in China.
Zhou H; Fu R; Wang H; Zhou F; Li H; Zhou Z; Zhang L; Yang R
Ann Hematol; 2013 Jan; 92(1):79-87. PubMed ID: 22956151
[TBL] [Abstract][Full Text] [Related]
14. Characteristics and management of primary and other immune thrombocytopenias: Spanish registry study.
Palau J; Sancho E; Herrera M; Sánchez S; Mingot ME; Upegui RI; Rodríguez Salazar MJ; de la Cruz F; Fernández MC; González López TJ; Hernández JJ; Ríos E; López-Fernández MF; García M; Hernández JÁ; Sanz MA
Hematology; 2017 Sep; 22(8):484-492. PubMed ID: 28415913
[TBL] [Abstract][Full Text] [Related]
15. Newly diagnosed immune thrombocytopenia adults: Clinical epidemiology, exposure to treatments, and evolution. Results of the CARMEN multicenter prospective cohort.
Moulis G; Germain J; Comont T; Brun N; Dingremont C; Castel B; Arista S; Sailler L; Lapeyre-Mestre M; Beyne-Rauzy O; Godeau B; Adoue D;
Am J Hematol; 2017 Jun; 92(6):493-500. PubMed ID: 28240787
[TBL] [Abstract][Full Text] [Related]
16. Rituximab versus splenectomy in persistent or chronic adult primary immune thrombocytopenia: an adjusted comparison of mortality and morbidity.
Moulis G; Sailler L; Sommet A; Lapeyre-Mestre M; Derumeaux H; Adoue D
Am J Hematol; 2014 Jan; 89(1):41-6. PubMed ID: 24038066
[TBL] [Abstract][Full Text] [Related]
17. [Epidemiology and pharmacoepidemiology of immune thrombocytopenia].
Moulis G; Lapeyre-Mestre M; Adoue D; Sailler L
Rev Med Interne; 2017 Jul; 38(7):444-449. PubMed ID: 28131440
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology and management of primary immune thrombocytopenia: A nationwide population-based study in Korea.
Lee JY; Lee JH; Lee H; Kang B; Kim JW; Kim SH; Lee JO; Kim JW; Kim YJ; Lee KW; Kim JH; Choi HS; Lee JS; Bang SM
Thromb Res; 2017 Jul; 155():86-91. PubMed ID: 28525829
[TBL] [Abstract][Full Text] [Related]
19. Chronic idiopathic thrombocytopenic purpura in adult Chinese patients: a retrospective single-centered analysis of 1791 cases.
Li HQ; Zhang L; Zhao H; Ji LX; Yang RC
Chin Med J (Engl); 2005 Jan; 118(1):34-7. PubMed ID: 15642223
[TBL] [Abstract][Full Text] [Related]
20. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura.
Braendstrup P; Bjerrum OW; Nielsen OJ; Jensen BA; Clausen NT; Hansen PB; Andersen I; Schmidt K; Andersen TM; Peterslund NA; Birgens HS; Plesner T; Pedersen BB; Hasselbalch HC
Am J Hematol; 2005 Apr; 78(4):275-80. PubMed ID: 15795920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
